Glial fibrillary acidic protein (GFAP) in blood has also shown changes in some non‐AD pathologies30, 31 but recent data have clearly demonstrated its dynamic change in response to amyloid and tau deposition.32, 33, 34, 35. This evidence concerns the gene GFAP and Alzheimer disease.